Supernus Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SUPN and other ETFs, options, and stocks.About SUPN
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products.
CEOJack A. Khattar
CEOJack A. Khattar
Employees652
Employees652
HeadquartersRockville, Maryland
HeadquartersRockville, Maryland
Founded2005
Founded2005
Employees652
Employees652
SUPN Key Statistics
Market cap1.65B
Market cap1.65B
Price-Earnings ratio1.27K
Price-Earnings ratio1.27K
Dividend yield—
Dividend yield—
Average volume330.24K
Average volume330.24K
High today$30.18
High today$30.18
Low today$29.18
Low today$29.18
Open price$29.46
Open price$29.46
Volume330.64K
Volume330.64K
52 Week high$38.09
52 Week high$38.09
52 Week low$21.99
52 Week low$21.99
SUPN News
Yahoo Finance 3d
Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024 - Yahoo FinanceSupernus Pharmaceuticals, Inc. ROCKVILLE, Md., April 24, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company fo...
Simply Wall St 3d
Subdued Growth No Barrier To Supernus Pharmaceuticals, Inc.'s Price - Simply Wall StThere wouldn't be many who think Supernus Pharmaceuticals, Inc.'s ( ) price-to-sales (or "P/S") ratio of 2.7x is worth a mention when the median P/S for the Pha...
